Questions about data manipulation [GxP / QC / QA]

posted by Helmut Homepage – Vienna, Austria, 2024-04-30 16:52 (350 d 17:32 ago) – Posting: # 23970
Views: 7,510

Hi QA,

❝ In this case there is always Sword of Damocles hanging over the sponsor head for their dossier because it can be affected by manipulation in another sponsor's BE study.

Correct. This was the case in the Synapse story. AFAIK, some companies tried to support their arguments by software. None was accepted and they remained on the hook. Only one sponsor succeeded to get off the list. No idea how they did it. There were also cases where the reference is no more on the market and therefore, it’s no possible to repeat a study. Bad luck.

❝ […] But in nut shell it is not possible to identify profile duplication with such checkpoints and procedure.

Correct. The only possibility I can think of is that the sponsor hires a team (‼) of monitors which is 24/7 at the site. Yep, get camp beds and sleeping bags. Be present at all phases of the study (clinical, analytical, data transfer, statistics). :-D
Don’t think that this was ever done.

❝ There should be availability of some robust system (may be regulators should come forward) which prevents the risk of sponsor (often pharma companies) and common man (using the approved medicines) and at the same time CROs not involved in such practices would be benefited.

You’re an optimist. Regulators will never share such information (i.e., tell who are the bad and good guys).
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,709 registered users;
37 visitors (0 registered, 37 guests [including 6 identified bots]).
Forum time: 10:24 CEST (Europe/Vienna)

A Camel is a Horse designed by committee.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5